Pictor Labs Unveils ClearStain™ for Enhanced Molecular Diagnostics
New virtual staining solution boosts molecular diagnostics performance, preserves tissue, and expedites results.
Pictor Labs, a frontrunner in AI-driven virtual staining and digital pathology, has launched its groundbreaking product, ClearStain™. This innovation is poised to transform molecular diagnostic workflows significantly. Following the successes of DeepStain™ and ReStain, ClearStain™ provides remarkable advantages for sequencing. It allows pathologists to visualize and annotate the specific tissues selected for testing directly from unstained slides. In comparative analyses, pathologists found tissues and tumors visualized through ClearStain™ to be visually similar to traditional stained slides, achieving an astounding accuracy of 99-100% across the regions assessed.
The debut of ClearStain™ at the emerging field events, such as the Society for Immunotherapy of Cancer (SITC) Annual Meeting, showcases Pictor Labs' advancements in precision medicine and digital pathology. Attendees will have the opportunity to witness firsthand how this virtual staining technology is shaping modern diagnostic methodologies.
ClearStain™ Reimagines Molecular Testing Workflows
ClearStain™ revolutionizes the molecular diagnostics landscape by producing AI-enhanced virtual H&E images from unstained slides. This cutting-edge technique facilitates real-time visualization, annotation, and quality control while effectively eliminating the need for adjacent slides and preserving samples. Essentially, what pathology professionals see in ClearStain™ is what they will sequence, ensuring greater accuracy and reliability in diagnostic testing.
By replacing traditional chemical H&E staining processes, ClearStain™ preserves invaluable tissue for follow-up assays, enhances tumor purity, and significantly reduces the rate of failures in sequencing processes.
Megan Rothney, Vice President of Product at Pictor Labs, emphasized, "With ClearStain™, previously challenging cases can now be restored and yield useful results. This innovation streamlines the sequencing workflow, minimizes potential pitfalls, enhances accuracy, and shortens turnaround times. ClearStain provides essential data for both patients and pathologists, allowing real-time guidance for molecular testing with confidence on the very tissue being examined, thereby ensuring vital information reaches patients who might have missed out previously."
Meeting the Demand for Digital Pathology Solutions
The digital pathology sector is witnessing a rapid evolution toward AI-supported tissue analysis and there is a growing necessity for interoperable solutions that effectively merge histological analysis with molecular data. ClearStain™ adeptly addresses this escalating demand by bridging the gap between traditional pathology and precision diagnostics. With its standardized and high-quality imaging outputs, ClearStain™ integrates seamlessly into existing digital pathology workflows, streamlining the process considerably.
By positioning Pictor Labs as a pivotal player in the digital sequencing ecosystem, ClearStain™ extends their leadership in virtual staining, vital to both tissue analysis and molecular diagnostic applications.
Building on Proven Technologies: DeepStain™ and ReStain
ClearStain™ complements the existing suite of high-fidelity virtual staining products from Pictor Labs, including DeepStain™ and ReStain. These solutions empower researchers to generate multiple stains from a single sample, solidifying Pictor Labs’ place at the forefront of AI-driven virtual histology. This synergy enhances discovery processes, safeguards vital samples, and boosts the efficiency of cancer research and diagnostics.
Rothney concluded, "We are laying the foundation for a future in precision pathology where every stain and pixel decision is rooted in data. ClearStain™ takes this mission a step further by connecting digital pathology with molecular diagnostics, ensuring more reliable results for clinicians and patients alike."
About Pictor Labs
Pictor Labs is dedicated to advancing the adoption of digital pathology on a global scale. Through its proprietary AI-imaging technology, the company produces diagnostic-quality virtual stains rapidly while ensuring tissue preservation for future analysis. Solutions such as DeepStain™, ReStain, and now ClearStain™ are establishing groundbreaking benchmarks for speed, reproducibility, and scalability in the fields of research and digital pathology.
Frequently Asked Questions
What is ClearStain™?
ClearStain™ is an innovative virtual staining solution from Pictor Labs that enhances molecular diagnostics workflows by enabling pathologists to visualize tissues directly from unstained slides.
How does ClearStain™ improve diagnostic accuracy?
The technology allows for real-time visualization and annotation of tissues, ensuring that pathologists can make informed decisions with high accuracy during molecular testing.
Where was ClearStain™ first presented?
ClearStain™ made its debut at key industry events like the Society for Immunotherapy of Cancer Annual Meeting, showcasing its potential impact on precision medicine.
What are the benefits of using ClearStain™ over traditional staining methods?
ClearStain™ eliminates the need for chemical stains, preserves tissue for further analysis, enhances tumor purity, and minimizes failures in sequencing processes.
Why is Pictor Labs significant in digital pathology?
Pictor Labs is at the forefront of digital pathology through AI-enhanced solutions like ClearStain™, DeepStain™, and ReStain, setting new standards for efficiency, quality, and precision in diagnostics.
